MFDS Forum Highlights Korea’s Shift To Regulatory Science Approach

Regulation Lag, Expertise Among Issues

At a recent forum organized by South Korea’s drug ministry, participants discussed why a regulatory science-based approach is needed, what issues in this area are being faced by the country and which directions it should be headed.

With the increasing introduction of new innovative medical products including digital therapeutics amid intensifying competition among countries to rapidly secure new technologies, South Korea is feeling the urgent need to shift its focus more to a regulatory science-based approach.

Regulatory innovation is already a key part of the government's broader steps to accelerate investment and grow the biopharma sector,...